Skip to main content
Clinical Trials/NCT03879096
NCT03879096
Completed
Not Applicable

Clinical and Functional Variables in the Assessment of Oncology Patient

University of Malaga1 site in 1 country120 target enrollmentMay 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer, Metastatic
Sponsor
University of Malaga
Enrollment
120
Locations
1
Primary Endpoint
Change from Cancer-Related Fatigue (CRF)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim is to analyse the effect of a Therapeutic Exercise and Education programme in several clinical and functional outcomes in cancer patient and survivors

Detailed Description

In the oncology field, both patients and survivors have to face several symptoms, like cancer-related fatigue or pain. Cancer patients also have affected quality of life, lower levels of function and they are at higher risk of weight gain following diagnosis. Given the risk of obesity, both exercise and diet play a key role in recovery from cancer. Hence, the aim of this study is to show the effect of a Therapeutic Exercise and Education programme (TEEP) in clinical and functional, including practical nutritional education in other clinical and functional secondary outcomes in cancer patients and survivors. Variables included are: body composition, mediterranean-diet adherence, quality of life (QoL) and functional outcomes (limb functionality, physical activity, physical function and handgrip strength). Furthermore, laboratory variables like muscle thickness (ecography) and muscle activity (electromyography) were included.

Registry
clinicaltrials.gov
Start Date
May 1, 2016
End Date
May 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Antonio I Cuesta-Vargas

Principal Researcher of CTS631 University of Malaga

University of Malaga

Eligibility Criteria

Inclusion Criteria

  • In the case of survivors: Patient who had been surgically treated for their primary tumour with no evidence of recurrence at the time of recruitment. The inclusion of patients undergoing hormonal treatment radiotherapy or antiHER therapy will be allowed.
  • In the case of cancer patients: patient who had been dignosed by cancer.
  • In both cases, all participants have to maintain the minimum physical function to perform exercise in group.

Exclusion Criteria

  • Patients were excluded if they had suffered any cardiovascular event defined as stable or unstable angor, acute pulmonary edema, cardiac rhythm disorders, or syncope of cause not affiliated in the year prior to inclusion

Outcomes

Primary Outcomes

Change from Cancer-Related Fatigue (CRF)

Time Frame: Prior and after intervention, an average of 3 months

The Spanish version of the Piper Fatigue Scale-Revised (PFS-R) will be used

Change from Upper limb functionality (%)

Time Frame: prior and after intervention, an average of 3 months

the Spanish version of Upper Limb Functional Index (ULFI) questionnaire will be filled

Change from Lower limb functionality(%)

Time Frame: prior and after intervention, an average of 3 months

the Spanish version of the Lower Limb Functional Index (LLFI) questionnaire will be filled

Change from Functional capacity

Time Frame: prior and after intervention, an average of 3 months

It will be tested by 30-second Sit-To-Stand Test (30-STS), number of repetitions completed.

Secondary Outcomes

  • Body Composition(prior and after intervention, an average of 3 months)
  • Change fromQuality of life (self-reported questionnaire)(prior and after intervention, an average of 3 months)
  • Change from specific Breast Cancer Quality of life (self-reported questionnaire)(prior and after intervention, an average of 3 months)
  • Change from Grip Strength (dynamometry)(prior and after intervention, an average of 3 months)
  • Change from fat mass(prior and after intervention, an average of 3 months)
  • Change from lean mass(prior and after intervention, an average of 3 months)
  • Change from water balance(prior and after intervention, an average of 3 months)
  • Change from Muscle thickness(prior and after intervention, an average of 3 months)
  • Change from Basal Metabolism(prior and after intervention, an average of 3 months)
  • Change from Body Mass Index(prior and after intervention, an average of 3 months)
  • Change from Physical activity (METS)(prior and after intervention, an average of 3 months)
  • Change from Handgrip Strength (Kg)(prior and after intervention, an average of 3 months)

Study Sites (1)

Loading locations...

Similar Trials